Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivo models to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by alpha smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concurrently, tissue inhibitors of metalloproteases (TIMPs) produced by HSCs are increased in experimental fibrosis, which could block the activity of their cognate enzymes and also prevent apoptosis of activated HSCs (278, 279).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Research works printed but not linked: 6
- Milani, 1992, Hepatology, 16, 186
- Vyas, 1995, 5, 399
- Saile, 1997, Am. J. Pathol., 151, 1265
- Li, 1999, Cancer Res., 59, 6267
- Ree, 1997, Clin. Cancer Res., 3, 1623
- Trim, 2000, Hepatology, 32, 183
Cited by
Items 301–400 of 431
Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice
Lam, H. Y. P., Liang, T.-R., Lan, Y.-C., Chang, K., Cheng, P.-C., & Peng, S.-Y. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.017 · Cited by 13
Role of ferroptosis in fibrosis diseases
Sun, Z., Zou, X., Bao, M., Huang, Z., Lou, Y., Zhang, Y., & Huang, P. C. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.04.024 · Cited by 16
Nieto, N. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02573.x · Cited by 13
Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies
Sokolović, A., van Roomen, C. P. A. A., Ottenhoff, R., Scheij, S. S., Hiralall, J. K., Claessen, N., Aten, J., Elferink, R. P. J. O., Groen, A. K., & Sokolović, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.012 · Cited by 15
“Liver fibrosis in Abcb4−/− mice was attenuated in fasting, most likely driven by downregulation of Tgfβ1, which reduced the number of activated HSC. Downregulation of a number of proinflammatory markers, a.o. Tnfα and Irf5 (a transcriptional activator of pro-inflammatory cytokines and chemokines [56]), clearly points…”
BackgroundInfluentialWen-xing, Z. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1278 · Cited by 13
Flisiak, R. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i43.6833 · Cited by 12
Alcoholic Liver Disease: A Synopsis of the Charles Lieber's Memorial Symposia 2009-2012
Neuman, M. G., Cohen, L., Zakhari, S., Nanau, R. M., Mueller, S., Schneider, M., Parry, C. D. H., Isip, R., & Seitz, H. K. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu021 · Cited by 12
“High levels of pro-fibrinogenic cytokines such as TGF-β and MMPs mediate fibrinogenesis in HCV and ALD patients (Neuman et al., 2001, 2002a,b; Murphy et al., 2002).”
BackgroundJiang, L., Fang, P., Weemhoff, J. L., Apte, U. M., & Pritchard, M. T. (2016) · BioMed Research International · doi:10.1155/2016/4918798 · Cited by 12
Effect of anluohuaxian tablet combined with γ-IFN on schistosomal liver fibrosis
Huang, J., Huang, H., Jiao, Y., Ai, G., Huang, T., Li, L., Yu, H., Ma, K., & Xiao, F. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0111-7 · Cited by 12
“They play an important role in the regulation of the ECM metabolism [10] . TIMP-1 is a essential member in the TIMPs family and produced by various connective tissue cells and hepatocytes, Kupffer cells, HSC as well as myofibroblasts in the liver [ 11 ] . The increased expression of TIMP-1 in liver tissue can advance…”
BackgroundSpindler, K. G., Christensen, I. J., Nielsen, H. J., Jakobsen, A. K. M., & Brünner, N. (2015) · Tumor Biology · doi:10.1007/s13277-015-3069-z · Cited by 11
Li, S., Lv, Y., Su, H., Zhang, Q.-N., Wang, L., & Hao, Z. (2016) · Scientific Reports · doi:10.1038/srep32155 · Cited by 13
Valva, P., Rios, D. A., Casciato, P. C., Gadano, A. C., Galdame, O., Müllen, E., Bertot, G. M., Matteo, E. D., & Preciado, M. V. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001079 · Cited by 12
Yeh, Y., Liang, C., Chen, M., Tsai, F., Lin, Y., Lee, M., Wu, J., & Kuo, C. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1046 · Cited by 11
“…Changhua, Taiwan, Grant/Award Number: RD107035; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Grant/Award Number: TCRD-TPE-108-25 K E Y W O R D S hepatic stellate cell, hsian-tsao, reactive oxygen species, apoptosis proteins (Friedman, 2010; Murphy et al., 2002).”
BackgroundMaia, J. M. D. C., Maranhão, H. D. S., de Sena, L. V., da Rocha, L. R. M., de Medeiros, I. A., & Ramos, A. M. D. O. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328326cab6 · Cited by 11
Expression of tissue inhibitor of matrix metalloproteinases-1 during aging in rat liver
Zhang, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i24.3696 · Cited by 11
Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.
Aldulaymi, B. H., Christensen, I. J., Sölétormos, G., Jess, P., Nielsen, S. E., Brünner, N., & Nielsen, H. J. (2010) · PubMed · Cited by 11
M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice
Rachakonda, V. P., Jadeja, R. N., Urrunaga, N. H., Shah, N., Ahmad, D., Cheng, K., Twaddell, W. S., Raufman, J., & Khurana, S. (2015) · Scientific Reports · doi:10.1038/srep14110 · Cited by 12
Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina
Kim, H. S., Vargas, A., Eom, Y. S., Li, J., Yamamoto, K. L., Craft, C. M., & Lee, E.-J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197322 · Cited by 11
Vu, H., Sun, Y., Xiong, Z., Tan, X., Radford‐Smith, D. E., Causer, A., Dickens, A. M., Hyötyläinen, T., Evstafev, I., Orešič, M., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101657 · Cited by 20
Abouelezz, H. M., Shehatou, G. S. G., Shebl, A. M., & Salem, H. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14256 · Cited by 12
“TIMP-1 also exerts an anti-apoptotic influence on HSCs by enhancing their survival through increasing expression of B cell lymphoma 2 (Bcl-2) proteins [7, 8].”
BackgroundSaed, G. M., Kruger, M. L., & Diamond, M. P. (2005) · European Journal of Plastic Surgery · doi:10.1007/s00238-005-0006-1 · Cited by 10
“Other recognized actions of TIMPs include inhibition of angiogenesis [20, 27] and suppression of apoptosis, which has been demonstrated in multiple cell types, including Burkitt’s lymphoma cell lines [21], hepatic stellate cells [ 26 ], and hippocampal neurons [39].”
BackgroundVinther, L., Lademann, U. A., Andersen, E. V., Højrup, P., Thaysen‐Andersen, M., Krogh, B. O., Viuff, B. M., Brünner, N., Stenvang, J., & Moreira, J. M. A. (2014) · Protein Expression and Purification · doi:10.1016/j.pep.2014.06.013 · Cited by 10
Matrix metalloproteinase targeted peptide vesicles for delivering anticancer drugs
Bhunia, D., Pradhan, K., Das, G., Ghosh, S., Mondal, P., & Ghosh, S. (2018) · Chemical Communications · doi:10.1039/c8cc05687k · Cited by 10
Cotreatment with interferon-α and -γ reduces liver fibrosis in a rat model
Takahara, T. (2004) · Hepatology Research · doi:10.1016/j.hepres.2003.11.003 · Cited by 10
Huang, X., Wang, X.-F., Wang, Y., Shen, S., Chen, W., Liu, T., Wang, P., Fan, X., Liu, L., Jia, J.-D., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00514 · Cited by 21
“7,8 We previously generated a recombinant adeno-associated virus (rAAV) harboring siRNA targeting the TIMP-1 gene (rAAV/siRNA-TIMP-1) and examined its impact on liver fibrosis in rats.”
BackgroundMethodKang, S. H., Yim, H. J., Hwang, J., Kim, M.-J., Lee, Y., Jung, Y. K., Kim, B., Kim, B., Park, H., Yeon, J. E., et al. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.138 · Cited by 9
“One study demonstrated that TIMP-1 inhibits apoptosis of activated HSCs by inhibiting MMP-1, resulting in fibrosis in vitro [31].”
BackgroundInfluentialChanges in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats
Marsillach, J., Ferré, N., Camps, J., Rull, A., Beltrán‐Debón, R., & Joven, J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9617-0 · Cited by 9
“through inhibitory effects on MMPs has been reported [26].”
BackgroundIL-6 and extracellular matrix remodeling.
Solís-Herruzo, J., de la Torre, P., Díaz-Sanjuán, T., García-Ruiz, I., & Muņoz-Yagüe, T. (2005) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082005000800006 · Cited by 3
Abubakr, S., Hazem, N. M., Sherif, R., Elhawary, A., & Botros, K. G. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02932-y · Cited by 9
“The potential for established liver fibrosis to be spontaneously reversed has been proven in experimental rat models [20, 46–48].”
BackgroundOverexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cells
Liu, L., Lai, Q.-N., Chen, J.-Y., Zhang, J.-X., & Cheng, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8858 · Cited by 8
New Mechanism of Selective Killing of Activated Hepatic Stellate Cells
Dodig, M., & Mullen, K. D. (2003) · Hepatology · doi:10.1002/hep.1840380432 · Cited by 8
Flisiak, R., Jaroszewicz, J., Łapiński, T. W., Flisiak, I., Rogalska, M., & Prokopowicz, D. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.06.002 · Cited by 8
Hepatic Stellate Cells and Fibrogenesis in Hepatitis C Virus Infection: An Ultrastructural Insight
Mansy, S. S., Elkhafif, N., AbelFatah, A. S., Yehia, H. A., & Mostafa, I. (2010) · Ultrastructural Pathology · doi:10.3109/01913120903506645 · Cited by 8
“Stellate cells are the principal source of MMP-2 and functional TIMP-1 and TIMP-2 [6].”
BackgroundUnraveling the Spider Web of Hepatic Stellate Cell Apoptosis
Pinzani, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.033 · Cited by 9
Niu, X., Meng, Y., Wang, Y., & Li, G. (2022) · Molecules · doi:10.3390/molecules27123738 · Cited by 7
Activity of lysosomal enzymes in the bile and serum of mice with intrahepatic cholestasis
Короленко, Т. А., Савченко, Н. Г., Yuz’ko, J. V., Alexeenko, T. V., & Sorochinskaya, N. V. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0147-x · Cited by 7
Wu, J., Chiu, V. J.-Y., Lan, C., Wang, M.-C., Tzeng, I., Kuo, C., & Hsieh, P. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8426051 · Cited by 7
Lee, J., Lee, S., Park, H.-J., Kim, Y., & Lee, S. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc21031 · Cited by 7
“In addition, TIMP1 expression was related to the inhibition of HSC apoptosis in vitro and the persistence of HSCs activated in vivo (15, 16).”
New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats
Niu, X., Wang, X., Niu, B., Wang, Y., He, H., & Li, G. (2022) · Pharmaceuticals · doi:10.3390/ph15010085 · Cited by 6
Kołakowski, A., Dziemitko, S., Chmielecka, A., Żywno, H., Bzdęga, W., Charytoniuk, T., Chabowski, A., & Konstantynowicz-Nowicka, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911380 · Cited by 8
“Moreover, it was presented that TIMP-1 is involved in the promotion of survival of various cells, including HSCs or endothelial cells through inhibition of MMP activity [74].”
BackgroundRamadan, A. E., Soliman, G. A., Mahmoud, S. S., Nofal, S. M., & Abdel-Rahman, R. F. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 6
Bean – an important element of a healthy diet. Nutritional values analysis
Wawryka, J., & Zdrojewicz, Z. (2016) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2016.0039 · Cited by 6
Gogulski, M., Ardois, M., Grabska, J., Libera, K., Szumacher‐Strabel, M., Cieślak, A., & Strompfová, V. (2020) · Medycyna Weterynaryjna · doi:10.21521/mw.6457 · Cited by 6
“Still, the direct antifibrotic properties of silybin are due to the fact that it not only inhibits the activation, differentiation, and mitosis of extracellular compoundsynthesizing cells in the liver (stellate cells), but it also interferes with the type 1 collagen synthesis pathway and decreases the production of me…”
BackgroundAntioxidative and Hepatoprotective Effects of Spirulina
Wu, L.-C., & Ho, J. A. (2007) · CRC Press eBooks · doi:10.1201/9781420052572.ch6 · Cited by 9
Abdel‐Latif, R. T., El-Abhar, H. S., Abdallah, D. M., Fawzy, I. M., & Mansour, S. M. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400846 · Cited by 5
Liu, M., Li, S., Xin, Y., Ji, S., Xie, R., & Xuan, S. (2015) · PubMed Central · Cited by 5
Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells
de Galarreta, M. R., Arriazu, E., de Obanos, M. P. P., Ansorena, E., & Iraburu, M. J. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00878-5 · Cited by 6
“Together with other processes, such as cellular senescence [14], clearance of activated HSC through apoptosis has been demonstrated to contribute to fibrosis regression both in animal models [11] and clinical studies [20].”
BackgroundThe effect and application of adiponectin in hepatic fibrosis
Chen, T., Yang, W., Dong, R., Yao, H., Sun, M., Wang, J., Zhou, Q. G., & Xu, J. (2023) · Gastroenterology report · doi:10.1093/gastro/goae108 · Cited by 8
Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis
Zheng, B., Tan, L., Mo, X., Yu, W., Wang, Y., Tucker‐Kellogg, L., Welsch, R. E., So, P. T. C., & Yu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026230 · Cited by 5
Frederiksen, C., Lykke, J., Christensen, I. J., Brünner, N., & Nielsen, H. J. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601166926 · Cited by 5
“For example, it has been shown to inhibit apoptosis [12,13], to stimulate proliferation [4,14] and to have pro and anti-angiogenic functions [15,16].”
BackgroundVoutilainen, S. H., Kosola, S. K., Tervahartiala, T. I., Sorsa, T. A., Jalanko, H., & Pakarinen, M. P. (2016) · Transplant International · doi:10.1111/tri.12879 · Cited by 5
“Activated HSCs produce ECM components, promoting secretion of MMPs and their tissue inhibitors (TIMPs) in concert with lymphocytes [5].”
BackgroundInfluentialp-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
Atif, M., Malik, M. N. H., Alsahli, T. G., Ali, M. M., Younis, W., Alharbi, K. S., Alzare, S. I., Alsuwayt, B., Maqbool, T., Anjum, İ., et al. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1054 · Cited by 4
Hassan, M. H., Salama, S. A., & Ismail, R. S. (2026) · Scientific Reports · doi:10.1038/s41598-025-32672-w · Cited by 4
“TIMP-1 not only inhibits MMPs but also protects activated HSCs from apoptosis 32,35,36 .”
Yoon, J., Piao, Z.-F., Hun, J., & Hoon, H. (2011) · InTech eBooks · doi:10.5772/22684 · Cited by 7
“portal hypertension were varix (41) and ascitis (34).”
BackgroundRebey, H. S. E., Aiad, H. A. S., Abulkheir, I. L. H., Asaad, N. Y., El‐Wahed, M. M. A., Abulkasem, F. M., & Mahmoud, S. F. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000154 · Cited by 4
Hepatic fibrosis: can we treat it clinically?
Das, K., & Chowdhury, A. (2008) · PubMed · Cited by 4
Congenital Hepatic Fibrosis, Caroli’s Disease, and Other Fibrocystic Liver Diseases
Rock, N. M., Kanavaki, I., & McLin, V. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_57 · Cited by 4
Moscoso, C. G., & Steer, C. J. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s213397 · Cited by 5
“Additionally, TIMP1 and TGFβ have been shown to have anti-apoptotic action and to promote survival of activated HSCs.(159)”
BackgroundInfluentialTak, K. Y., Kim, J., Park, M., Kim, W., Lee, S., Park, N., Kim, M. J., Kang, J.-B., Koh, Y., Yang, H. Y., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00857-7 · Cited by 4
“Myofibroblasts are crucial for both normal wound healing and fibrosis because they produce large amounts of ECM and remodel it by secreting matrix metalloproteinases and tissue inhibitors of metalloproteinases 52,53 .”
Islam, M. A., Mawya, J., Salma, U., Kasim, N. H. A., & Haque, N. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i11.111090 · Cited by 4
Analysis of Gene Expression in 4,4'-Methylenedianiline-induced Acute Hepatotoxicity
Oh, J., Yoon, H.-J., Lim, J., Park, H., Cho, J., Kwon, M.-S., & Yoon, S. (2009) · Toxicological Research · doi:10.5487/tr.2009.25.2.085 · Cited by 3
“In addition, overexpression of Timp1 is known to block the proliferation (Martin et al., 1999) and have anti-apoptotic function in hepatic stellate cells (Murphy et al., 2002).”
BackgroundScorneaux, B., Thomas, G., Hopkins, S., & Harris, R. R. (2010) · Journal of Hepatology · doi:10.1016/s0168-8278(10)60668-x · Cited by 3
“TIMP-1 has been reported to promote cell growth and inhibit apoptosis (Murphy et al., 2002).”
BackgroundAl‐Humadi, H., Al-Humadi, A. W., Al‐Saigh, R., Strilakou, A. A., Lazaris, A. C., Gazouli, M., & Liapi, C. A. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13013 · Cited by 3
New Insights to Prevent Liver Fibrosis by Targeting YB-1 and Collagen Genes
Guntaka, R. V. (2019) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.1901014 · Cited by 4
MMP-9 mRNA Expression and Bridging Fibrosis Progression in Toxic Liver Injury
Lebedeva, E. I., Babenka, A. S., & Shchastniy, A. T. (2023) · Acta Naturae · doi:10.32607/actanaturae.17856 · Cited by 3
Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis
Lotersztajn, S., & Mallat, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00011-7 · Cited by 4
Hepatic Fibrosis in Hepatitis C
Sheiko, M. A., & Rosen, H. R. (2016) · Springer eBooks · doi:10.1007/978-4-431-56101-9_3 · Cited by 4
The Role of Endoplasmic Reticulum Stress in the Development of Fibrosis in Crohn’s Disease
Li, C. R. (2018) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2018.00003 · Cited by 3
Chen, L., Yang, H., Wang, J., Zhang, H., Fu, K., Yan, Y., & Liu, Z. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011622 · Cited by 2
“Fortunately, growing evidence suggests that hepatic fibrosis is reversible in both patients and experimental fibrotic models [40,41].”
Hao, M., Chen, Z., Wang, P., Lu, Y., An, D., Yang, Q., Han, X., Wang, K., Sang, X., & Cao, G. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120090 · Cited by 2
EFFECT OF COLLAGEN I GEL ON APOPTOSIS OF RAT HEPATIC STELLATE CELLS
Bittnerová, L., Jiroutová, A., Rudolf, E., Řezáčová, M., & Kanta, J. (2013) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2014.27 · Cited by 2
“5 μM GLT (Sigma) for 5 hours (18), 75 μM CHX (Calbiochem Merck, Prague) for 14 hours (16) or 5 μg/ml (0.”
BackgroundMethodAnti‐fibrotic therapy: Are matrix metalloproteinases friends or foes?
Yoshiji, H. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00573.x · Cited by 2
Congenital Hepatic Fibrosis, Caroli’s Disease, and Other Fibrocystic Liver Diseases
Rock, N. M., Kanavaki, I., & McLin, V. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_60 · Cited by 3
Cell–ECM Interactions in Repair and Regeneration
Petreaca, M. L., & Martins‐Green, M. M. (2008) · Elsevier eBooks · doi:10.1016/b978-012369410-2.50007-3 · Cited by 4
Noninvasive Assessment of Disease Progression
Tapper, E. B., & Afdhal, N. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00008-2 · Cited by 2
Cell–ECM Interactions in Repair and Regeneration
Petreaca, M. L., & Martins‐Green, M. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00017-2 · Cited by 4
Iwai, S., Kamiya, Y., Tsujiyama, K., Murayama, M., Tsuchiya, H., Tomita, Y., Kawakami, T., Yura, A., Okazaki, M., & Oguchi, K. (2008) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms1989.20.11 · Cited by 2
Короленко, Т. А., Филатова, Т. Г., Савченко, Н. Г., Валерьевна, Ю. Ю., Goncharova, I. A., & Alexeenko, T. V. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0098-7 · Cited by 2
Research of inhibition of survivin in rat HSC-T6 cell by siRNA interference
Yang, M., Li, D. F., & Nie, Y. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_084 · Cited by 1
“HSC also impedes the degradation of ECM and activates further static HSC by secreting tissue inhibitor of metalloproteinase (TIMPs) (18) and transforming growth factor β (TGF-β) (19), which forms a vicious circle diffi cult to be reversed.”
Regulation of Proteolysis in Vascular Remodeling
Mandel, E. R., Uchida, C. L., & Haas, T. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9099-9_16 · Cited by 2
[Progress in myofibroblast and its application in forensic medicine].
Yu, T.-S., Yue, L., & Guan, D.-W. (2013) · PubMed · Cited by 1
Bae, J., Jang, E., & Lee, J. H. (2018) · 대한한의학회지 · doi:10.13048/jkm.18033
Fibrosis as a Major Mechanism of Chronic Liver Disease
Bechmann, L. P., & Friedman, S. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_5 · Cited by 3
“In addition to its role in inhibiting proteases, TIMP-1 is also antiapoptotic towards HSCs, and thus its expression preserves the population of activated HSC by preventing their clearance ( 32 ).”
BackgroundThe healthy and diseased extracellular matrix of the liver
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00009-3 · Cited by 1
Ju, K., Liu, X., Wang, Q., Liu, X., Li, D., & Tan, B. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16985 · Cited by 2
Complications of Liver Disease
Lidbury, J. A. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.03.008 · Cited by 2
Apoptotic cell death as a target for the treatment of acute and chronic liver injury
Schoemaker, M. H. (2004) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Jamil, A., & Iredale, J. P. (2007) · Springer eBooks · doi:10.1007/0-387-33650-8_11 · Cited by 1
Self-citationWarner, R. B. (2013) · Human Biology · Cited by 1
Apoptosis in cartilage and bone resorption
GIBSON, G. J. (2003) · Current Opinion in Orthopedics · doi:10.1097/00001433-200310000-00005 · Cited by 1
Effects of hepatocyte growth factor on fibrosis and hepatic expression of MMP-1 andTIMP-1
Song, L.-L., Luo, H.-S., & Yu, B.-P. (2003) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v11.i2.209 · Cited by 1
Friedman, S. L. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch12 · Cited by 1
Friedman, S. L. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch10 · Cited by 1
Stone, L. C. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Ferrer, A. P. (2005) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
19. THE ROLE OF THE HEPATIC STELLATE CELL IN LIVER FIBROSIS
Kendall, T. J., & Iredale, J. P. (2004) · Principles of medical biology · doi:10.1016/s1569-2582(04)15019-8
Self-citationAddressing liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells
Adrian, J. E. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Role of thyroid hormone in the intestinal development of Eleutherodactylus coqui
Singamsetty, S. (2009)
Muche, M. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5807
Metadata
- Authors
- Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H.
- Affiliations
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Murphy, Frank R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11069-11076
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164407945
- Cited by
- 432
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TIMP-1, hepatic stellate cells, apoptosis, matrix metalloproteinase inhibition, liver fibrosis, liver cirrhosis, alpha-smooth muscle actin, collagenase, serum deprivation, cycloheximide, nerve growth factor, TIMP-1 mRNA expression
- MeSH terms
- Animals, Cell Division, Cells, Cultured, Cycloheximide, Humans, Liver, Liver Cirrhosis, Apoptosis, Tissue Inhibitor of Metalloproteinase-1, Caspases, In Situ Nick-End Labeling, Rats, Caspase 3, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.